Frequently Asked Questions

Patient education and transparent clinical communication are essential components of reproductive healthcare. For individuals exploring fertility treatments, understanding clinical procedures, diagnostic evaluations, and structured care pathways helps address common medical questions. Review the frequently asked questions regarding infertility evaluations and treatments with Dr. Prasenjit Kr. Roy.

Q. What is Laparoscopy?

Laparoscopy is an operation done to look inside your abdomen with a thin instrument called a laparoscope. Through small holes in your tummy, the doctor looks, examines and operates (if needed) without making large cuts.

In conventional surgery a long incision is made to gain entry into the abdominal cavity and operate. This result in increased post-operative pain, longer stay in hospital, delayed recovery, long and ugly scars, higher chance of wound infection and a higher chance of hernia. The incidence of all these are considerably reduced by a laparoscopic surgery.

There may be some discomfort in the abdomen for a day or two after laparoscopy due to the presence of some carbon dioxide gas. If the surgery is uneventful, feeding can be started on the same day once the patient has recovered completely from the effects of anesthesia. Before you go home you will be given advice about caring for the surgical wounds and when you will need to come back for a follow-up appointment or to have stitches removed. Complete recovery may take longer if any surgery has been carried out. It is important to follow the advice of your surgeon about physical activity, rest and returning to work.

A hysteroscopy is an operation done to evaluate the inside of the uterine cavity and if necessary operate on the same.

A narrow telescope with an illuminated lens at its end is introduced in the uterine cavity through the cervix or neck of the womb. For clear vision, the uterine cavity needs to be distended, which is done with gas or some fluid.

Hysteroscopy for diagnostic purposes is usually performed to assess the cause of sub fertility or find out the cause of abnormal bleeding. It may also be done to remove polyps, resect septae, release adhesions and retrieve lost IUCDs.

  • A woman's most fertile time is during ovulation. Ovulation typically occurs within day 11 through day 21 of a woman's cycle.
  • Counting from the first day of a woman's last period, day 1 is the first day a woman starts bleeding, and the 11th day is most likely the earliest day a woman will ovulate. The 21st day is most likely the last. A woman's period comes between the 28th and 32nd day of the cycle. This pattern may differ slightly with each woman depending on a variety of factors.
  • Infertility is a medical condition that is found in both men and women, and men and women are affected almost equally.
  • With men, declining sperm counts, testicular abnormalities, and associated factors are common causes of infertility.
  • With women, the most common causes are tubal blockage, endometriosis, PCOS, and advanced maternal age which affects egg quality and quantity.

Infertility is a disease of the reproductive system that impairs one of the body's most basic functions: the conception of children. Conception is a complicated process that depends upon many factors: on the production of healthy sperm by the man and healthy eggs by the woman; unblocked fallopian tubes that allow the sperm to reach the egg; the sperm's ability to fertilize the egg when they meet; the ability of the fertilized egg (embryo) to become implanted in the woman's uterus; and sufficient embryo quality.

Finally, for the pregnancy to continue to full term, the embryo must be healthy and the woman's hormonal environment adequate for its development. When just one of these factors is impaired, infertility can result.

In rough terms, about one-third of infertility cases can be attributed to male factors, and about one-third to factors that affect women. For the remaining one-third of infertile couples, infertility is caused by a combination of problems in both partners or, in about 20 percent of cases, is unexplained.

The most common male infertility factors include azoospermia (no sperm cells are produced) and oligospermia (few sperm cells are produced). Sometimes, sperm cells are malformed or they die before they can reach the egg. In rare cases, infertility in men is caused by a genetic disease such as cystic fibrosis or a chromosomal abnormality.

The most common female infertility factor is an ovulation disorder. Other causes of female infertility include blocked fallopian tubes, which can occur when a woman has had pelvic inflammatory disease or endometriosis (a sometimes painful condition causing adhesions and cysts). Congenital anomalies involving the structure of the uterus and uterine fibroids are associated with repeated pregnancy losses.

Couples are generally advised to seek medical help if they are unable to achieve pregnancy after a year of unprotected intercourse. The doctor will conduct a physical examination of both partners to determine their general state of health and to evaluate physical disorders that may be causing infertility. Usually both partners are interviewed about their medical and lifestyle habits in order to determine appropriate clinical evaluations.

If no cause can be determined at this point, more specific tests may be recommended. For women, these include an analysis of ovulation, imaging of the fallopian tubes and uterus, and diagnostic laparoscopy. For men, initial tests focus on comprehensive semen analysis.

Many infertility cases are managed with conventional medical therapies, such as pharmacological treatment or surgical repair of reproductive structures.

Infertility often creates significant emotional challenges for couples. Coping with medical decisions and clinical uncertainties can create emotional stress. Professional counseling and support are beneficial during this journey.

No, infertility is not solely a woman's condition. In about one-third of cases, infertility is due to female factors. In another third of cases, it is due to male factors. The remaining cases are caused by a combination of male and female factors or by unexplained etiologies.

Infertility in men is most often caused by:

  • Problems with sperm production, such as producing too few sperm or none at all
  • Problems with sperm motility or morphology affecting the ability to reach and fertilize the egg

Sometimes male factor infertility is congenital, while other times it develops later in life due to medical conditions, illness, or injury.

The concentration and quality of spermatozoa can be affected by overall health and lifestyle factors, including:

  • Alcohol consumption
  • Substance use
  • Environmental and occupational toxins
  • Cigarette smoking
  • Underlying health conditions
  • Certain medications
  • Oncological treatments such as radiation and chemotherapy
  • Advanced paternal age

Ovulatory disorders account for a significant proportion of female infertility cases. Signs of ovulatory dysfunction include irregular or absent menstrual cycles.

Other causes of female fertility factors include:

  • Tubal occlusion due to pelvic inflammatory disease, endometriosis, or previous ectopic pregnancy surgery
  • Anatomical uterine conditions
  • Uterine fibroids

Various clinical and lifestyle factors can influence female reproductive health, including:

  • Advanced maternal age
  • Chronic stress
  • Nutritional status
  • Extreme physical exertion
  • Body mass index extremes (underweight or overweight)
  • Tobacco use
  • Alcohol consumption
  • Sexually transmitted infections
  • Endocrine and hormonal disorders

Female infertility is managed through structured medical and surgical protocols, including:

• Laparoscopy - Patients diagnosed with tubal or pelvic pathology may undergo surgical correction or assisted reproductive technologies such as in vitro fertilization (IVF). Laparoscopic intervention allows for adhesiolysis, endometriosis treatment, cystectomy, and tubal evaluation.

• Hysteroscopy - Hysteroscopic evaluation allows for the resection of polyps and submucosal fibroids, division of intrauterine adhesions, and correction of cavity abnormalities.

• Medical Therapy - Ovulation induction medications may be prescribed for ovulatory dysfunction. Insulin-sensitizing agents may be utilized for patients with polycystic ovary syndrome (PCOS).

• Intrauterine Insemination - A clinical procedure where prepared spermatozoa are placed directly into the uterine cavity timed with ovulation.

• In Vitro Fertilization (IVF) - An assisted reproductive technology where oocytes are fertilized in a specialized laboratory setting and resulting embryos are transferred to the uterus.

• ICSI - Intracytoplasmic sperm injection utilized for male factor infertility, involving the microinjection of a single spermatozoon into an oocyte.

• Donor Oocyte Programs - Assisting patients with diminished ovarian reserve or specific indications through established donor egg protocols.

Oocyte retrieval is a minor surgical procedure performed under sedation. The duration depends on follicular count and ovarian accessibility, typically taking between 20 to 30 minutes.

Oocyte retrieval is performed under monitored anesthesia care so patients remain asleep and comfortable throughout the procedure without requiring a breathing tube, minimizing typical anesthetic side effects.

Clinical data indicates that standard oocyte retrieval does not impair future ovarian function. Patients frequently undergo multiple stimulation cycles successfully when clinically indicated.

Minor vaginal spotting can occasionally occur from the vaginal puncture sites and typically resolves promptly.

Not necessarily. While oocytes are retrieved from mature follicles, ovarian stimulation cycles can yield a variable proportion of immature or empty follicles.

Embryo transfer is a straightforward clinical procedure performed without anesthesia, comparable in sensation to a routine speculum examination or intrauterine insemination.

Extended bed rest is generally not required following embryo transfer. Patients are advised to resume normal light daily activities while avoiding strenuous physical exertion.

Embryo developmental competence is primarily determined by chromosomal and biological factors. Specialized laboratory techniques such as assisted hatching may be utilized in selected clinical indications.

Assisted hatching is performed selectively based on specific clinical criteria, such as advanced maternal age or previous implantation failure.

Surplus viable embryos of good quality may be cryopreserved (frozen) for future use in accordance with patient consent and applicable medical guidelines.

A quantitative blood pregnancy test (beta-hCG) is typically scheduled 12 to 14 days following oocyte retrieval to ensure accurate results.

A recovery period of at least one full menstrual cycle is generally recommended between consecutive IVF cycles to allow physiological recovery.

Treatment planning is individualized based on clinical response, prognostic factors, and patient goals discussed during medical consultations.

Call Now